The Institut Pasteur has uncovered a previously unknown mechanism of action for lenacapavir. This treatment does more than simply block the virus from entering the cell: it acts directly within the nucleus, redirecting HIV to areas of the DNA where it can no longer replicate effectively. This discovery helps explain the remarkable long-term efficacy of this compound.
Source : Institut Pasteur
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.